I am a woman of reproductive age trying to conceive; my anti‑Müllerian hormone (AMH) level is 1.98 ng/mL—does this indicate a normal ovarian reserve and what fertility steps should I take?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

AMH 1.98 ng/mL: Interpretation and Fertility Management

Your AMH level of 1.98 ng/mL indicates normal ovarian reserve for a woman of reproductive age, and you should proceed with attempting natural conception while monitoring your menstrual cycles. 1

Understanding Your AMH Result

Your AMH value falls within the normal range and does not suggest diminished ovarian reserve. Based on age-specific reference ranges used in clinical studies:

  • Low AMH is typically defined as <1.0–1.1 ng/mL 2
  • Medium AMH ranges from approximately 1.0–2.0 ng/mL 2
  • Your level of 1.98 ng/mL places you at the upper end of medium or lower end of high AMH, depending on the specific assay used 2

AMH represents the best endocrine marker for assessing age-related decline in ovarian reserve in healthy women, as it reflects the pool of growing follicles that can potentially ovulate. 1, 3

Fertility Implications

Pregnancy potential: Your AMH level does not indicate reduced fertility potential. Studies examining AMH and natural fertility show that women with AMH values above 0.7 ng/mL have similar pregnancy rates after 12 cycles of attempting conception compared to those with higher values. 4

Miscarriage risk: Your AMH level is reassuring regarding miscarriage risk. Meta-analysis data demonstrates that women with low AMH (<1.0–1.1 ng/mL) face increased miscarriage risk (OR 1.35; 95% CI 1.10–1.66), but your level of 1.98 ng/mL places you outside this risk category. 2

Recommended Fertility Steps

Immediate Actions

  • Attempt natural conception for 6–12 months if you are under age 35, or for 6 months if you are age 35 or older 5
  • Track menstrual regularity as irregular cycles may warrant earlier evaluation regardless of AMH level 1
  • Optimize preconception health including folic acid supplementation and addressing any underlying medical conditions

When to Seek Fertility Evaluation

Pursue fertility evaluation if:

  • No pregnancy after 12 months of regular unprotected intercourse (if <35 years old)
  • No pregnancy after 6 months of regular unprotected intercourse (if ≥35 years old)
  • Menstrual irregularities develop
  • Any symptoms suggesting ovarian dysfunction emerge 1

Additional Testing Considerations

While your AMH is reassuring, comprehensive fertility assessment includes:

  • FSH and estradiol measured on cycle days 2–5 to complement AMH findings 1
  • Transvaginal ultrasound with antral follicle count (AFC), which strongly correlates with AMH and provides additional ovarian reserve information 1
  • TSH and prolactin to exclude thyroid disease and hyperprolactinemia as causes of potential ovulatory dysfunction 1

Important Caveats

Assay variability: Different AMH assay platforms (Gen II ELISA, Elecsys) can produce disparate absolute values, so your result should be interpreted using your specific laboratory's reference ranges. 1, 3 The lack of international standardization means that repeat testing should ideally use the same assay platform. 3, 6

Age-specific interpretation: AMH reference ranges are age-dependent, with values naturally declining with advancing reproductive age. Your result should be interpreted in the context of your specific age. 1

Limited predictive value for natural fertility: While AMH excellently predicts ovarian response to IVF stimulation, it has limited value in predicting natural conception rates or ongoing pregnancy in the general population attempting natural conception. 6, 4

AMH does not diagnose premature ovarian insufficiency: No recommendations exist for using AMH alone to diagnose premature ovarian insufficiency, as its diagnostic value in this context remains unestablished. 1

References

Guideline

Ovarian Function Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function.

The Journal of clinical endocrinology and metabolism, 2020

Research

Anti-Müllerian hormone as a predictor of reproductive potential.

Current opinion in endocrinology, diabetes, and obesity, 2018

Guideline

Implications of Low AMH Levels on Fertility

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.